Piperazine Derivatives for Therapeutic Use: a Patent Review (2010-present)
Overview
Affiliations
Introduction: Piperazine, a six membered nitrogen containing heterocycle, is of great significance to the rational design of drugs. This moiety can be found in a plethora of well-known drugs with various therapeutic uses, such as antipsychotic, antihistamine, antianginal, antidepressant, anticancer, antiviral, cardio protectors, anti-inflammatory, and imaging agents. Slight modification to the substitution pattern on the piperazine nucleus facilitates a recognizable difference in the medicinal potential of the resultant molecules.
Areas Covered: Scifinder was the main source used to search for patents containing piperazine compounds with therapeutic uses. The article describes a variety of molecular designs bearing piperazine entity furnishing CNS agents, anticancer, cardio-protective agents, antiviral, anti-tuberculosis, anti-inflammatory, antidiabetic, and antihistamine profiles, as well as agents relieving pain and useful in imaging applications.
Expert Opinion: The great interest gathered to explore piperazine based molecules in relatively few years reflects the broad potential of the entity. Earlier, this scaffold was considered to express CNS activity only. However, a significant increase in research covering studies of several different activities of piperazine ring suggest a successful emergence of the pharmacophore. Certain patents outlined in the present article recommend that piperazines can be a flexible building block to discover drug-like elements and modification of substituents present on the piperazine ring may have a significant impact on the pharmacokinetic and pharmacodynamics factors of the resulting molecules. This article aims to provide insights to piperazine based molecular fragments that would assist drug discoverers to rationally design molecules for various diseases. We anticipate, and highly recommend, further therapeutic investigations on this motif.
Chen Y, Li H, Liu J, Ni J, Deng Q, He H Front Pharmacol. 2024; 15:1496131.
PMID: 39660007 PMC: 11629013. DOI: 10.3389/fphar.2024.1496131.
Mushtaq A, Ahmad M, Zahoor A, Kamal S, Ali K, Javid J RSC Adv. 2024; 14(50):37521-37538.
PMID: 39582937 PMC: 11583631. DOI: 10.1039/d4ra05649c.
Zahedifard F, Bansal M, Sharma N, Kumar S, Shen S, Singh P PLoS Negl Trop Dis. 2024; 18(3):e0012050.
PMID: 38527083 PMC: 10994559. DOI: 10.1371/journal.pntd.0012050.
Parallel Synthesis of Piperazine Tethered Thiazole Compounds with Antiplasmodial Activity.
Rayala R, Chaudhari P, Bunnell A, Roberts B, Chakrabarti D, Nefzi A Int J Mol Sci. 2023; 24(24).
PMID: 38139243 PMC: 10743568. DOI: 10.3390/ijms242417414.
Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancer.
Sun J, Baker J, Russell C, Pham H, Goldsmith C, Cossar P RSC Med Chem. 2023; 14(11):2246-2267.
PMID: 37974967 PMC: 10650957. DOI: 10.1039/d2md00289b.